Abstract
Experimental and epidemiologic studies indicated that calcium-sensing receptor (CaSR) polymorphisms were associated with cancer risk, yet no data are available for candidate gene and hepatocellular carcinoma (HCC) risk. To address this, we evaluated whether CaSR rs17251221 polymorphism is associated with HCC susceptibility, clinicopathological parameters, and prognosis in HCC patients treated by TACE. A TaqMan assay was used to genotype rs17251221 SNP in this case (n = 843)–control (n = 783) study. A significant increased risk of HCC was observed in patients carrying rs17251221 GG (adjusted OR 1.355, 95 % CI 1.024–1.793, P = 0.033), AG/GG genotype (adjusted OR 1.254, 95 % CI 1.007–1.561, P = 0.043), and G allele (adjusted OR 1.163, 95 % CI 1.013–1.335, P = 0.032). Furthermore, a significant association was found between Child-Pugh class, serum BCLC stage, and AFP level and rs17251221 genotypes. More importantly, individuals carrying rs17251221 AG, GG genotype showed significantly longer MST than AA genotype and significant hazard ration (AG: adjusted HR 0.484, 95 % CI 0.406–0.577, P < 0.001; GG: adjusted HR 0.633, 95 % CI 0.575–0.697, P < 0.001, respectively). Meanwhile, we found a favorable HR for AG/GG genotype carriers (adjusted HR 0.645, 95 % CI 0.542–0.768, P < 0.001). These results indicated that CaSR rs17251221 polymorphism is associated with susceptibility to HCC, and rs17251221 G allele genotype showed significant independent better prognosis of HCC patients treated with TACE.
Similar content being viewed by others
Abbreviations
- CaSR :
-
Calcium-sensing receptor
- SNPs:
-
Single-nucleotide polymorphisms
- HCC:
-
Hepatocellular carcinoma
- HBV:
-
Hepatitis B virus
- HBsAg:
-
Hepatitis B surface antigen
- AFP:
-
Alpha fetoprotein
- MST:
-
Median survival time
- DFS:
-
Disease-free survival
- OS:
-
Overall survival
- FEM:
-
Regimen, 5-fluorouracil, epirubicin, and mitomycin-C
- TACE:
-
Transhepatic arterial chemotherapy and embolization
- OR:
-
Odds ratio
- CI:
-
Confidence interval
- HR:
-
Hazard ratio
References
Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2014. doi:10.1002/hep.27388.
Chen JG, Zhu J, Zhang YH, Chen YS, Ding LL, Lu JH, Zhu YR. Trends in the mortality of liver cancer in Qidong, China: an analysis of fifty years. Zhonghua Zhong Liu Za Zhi. 2012;34(7):532–7.
Ding J, Wang H. Multiple interactive factors in hepatocarcinogenesis. Cancer Lett. 2014;346(1):17–23.
Yang Y, Zhang D, Feng N, Chen G, Liu J, Chen G, Zhu Y. Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis. Gastroenterology. 2014. doi:10.1053/j.gastro.
Fernández-Rodríguez CM, Gutiérrez-García ML. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B. World J Gastrointest Pharmacol Ther. 2014;5(3):175–82.
Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature. 1993;366:575–80.
Canaff L, Petit JL, Kisiel M, Watson PH, Gascon-Barre M, Hendy GN. Extracellular calcium- sensing receptor is expressed in rat hepatocytes. Coupling to intracellular calcium mobilization and stimulation of bile flow. J Biol Chem. 2001;276:4070–9.
Cifuentes M, Rojas CV. Antilipolytic effect of calcium-sensing receptor in human adipocytes. Mol Cell Biochem. 2008;319:17–21.
Bai M. Structure and function of the extracellular calcium-sensing receptor (review). Int J Mol Med. 1999;4:115–25.
Xie R, Tang B, Yong X, Luo G, Yang SM. Roles of the calcium sensing receptor in digestive physiology and pathophysiology (review). Int J Oncol. 2014. doi:10.3892/ijo.2014.2560.
Xing WJ, Kong FJ, Li GW, Qiao K, Zhang WH, Zhang L, Bai SZ, Xi YH, Li HX, Tian Y, Ren H, Wu LY, Wang R, Xu CQ. Calcium-sensing receptors induce apoptosis during simulated ischaemia-reperfusion in Buffalo rat liver cells. Clin Exp Pharmacol Physiol. 2011;38(9):605–12.
Kapur K, Johnson T, Beckmann ND, Sehmi J, Tanaka T, Kutalik Z, Styrkarsdottir U, Zhang W, Marek D, Gudbjartsson DF, Milaneschi Y, Holm H, Diiorio A, Waterworth D, Li Y, Singleton AB, Bjornsdottir US, Sigurdsson G, Hernandez DG, Desilva R, Elliott P, Eyjolfsson GI, Guralnik JM, Scott J, Thorsteinsdottir U, Bandinelli S, Chambers J, Stefansson K, Waeber G, Ferrucci L, Kooner JS, Mooser V, Vollenweider P, Beckmann JS, Bochud M, Bergmann S. Genome-wide meta-analysis for serum calcium identifies significantly associated SNPs near thecalcium-sensing receptor (CASR) gene. PLoS Genet. 2010;6(7):e1001035.
Chou YH, Woon PY, Chen WC, Hsu YW, Chang JM, Hwang DY, Chiu YC, Kuo HC, Chang WP, Hou MF, Liu ME, Chang JG, Chang WC. A genetic polymorphism (rs17251221) in the calcium- sensing receptor gene (CASR) is associated with stonemultiplicity in calcium nephrolithiasis. PLoS One. 2011;6(9):e25227.
Jorde R, Schirmer H, Njølstad I, Løchen ML, Bøgeberg ME, Kamycheva E, Figenschau Y, Grimnes G. Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study. Eur J Epidemiol. 2013;28(7):569–78.
Li X, Kong X, Jiang L, Ma T, Yan S, Yuan C, Yang Q. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis. Cell Physiol Biochem. 2014;33(1):165–72.
Singh N, Promkan M, Liu G, Varani J, Chakrabarty S. Role of calcium sensing receptor (CaSR) in tumorigenesis. Best Pract Res Clin Endocrinol Metab. 2013;27:455–63.
Chakrabarty S, Radjendirane V, Appelman H, Varani J. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: Promotion of e-cadherin expression and suppression of beta-catenin/tcf activation. Cancer Res. 2003;63:67–71.
O’Seaghdha CM, Yang Q, Glazer NL, Leak TS, Dehghan A, Smith AV, Kao WH, Lohman K, Hwang SJ, Johnson AD, GEFOS Consortium, Hofman A, Uitterlinden AG, Chen YD, GEFOS Consortium, Siscovick DS, Harris TB, Psaty BM, Coresh J, Gudnason V, Witteman JC, Liu YM, Kestenbaum BR, Fox CS, Köttgen A. Common variants in the calcium-sensing receptor gene are associated with total serumcalcium levels. Hum Mol Genet. 2010;19(21):4296–303.
Liu G, Hu X, Chakrabarty S. Calcium sensing receptor down-regulates malignant cell behavior and promotes chemosensitivity in human breast cancer cells. Cell Calcium. 2009;45(3):216–25.
Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG. Mutations in the human Ca2+ -sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 1993;5:1297–303.
Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev. 2001;81:239–97.
Magno AL, Ward BK, Ratajczak T. The calcium-sensing receptor: A molecular perspective. Endocr Rev. 2011;32:3–30.
Reh CM, Hendy GN, Cole DE, Jeandron DD. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet. J Clin Endocrinol Metab. 2011;96:E707–12.
Pidasheva S, Grant M, Canaff L, Ercan O, Kumar U, Hendy GN. Calcium-sensing receptor dimerizes in he endoplasmic reticulum: biochemical and biophysical characterization of casr mutants retained intracellularly. Hum Mol Genet. 2006;15:2200–9.
Acknowledgments
The authors gratefully acknowledge the efforts and contributions of doctors, nurses and technical staff at the Shengjing Hospital of China Medical University and First Hospital of Dalian Medical University.
Conflict of interest
None of the authors have any financial or other interests that could be construed as a conflict of interest with regard to the submitted manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, Q., Zhao, Y., Wang, Y. et al. A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy. Med Oncol 31, 267 (2014). https://doi.org/10.1007/s12032-014-0267-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-014-0267-2